Micron Biomedical, Inc.

Micron develops pharmaceutical products, based on its proprietary microneedle patch technology, that are designed to provide enhanced vaccines and proprietary drugs efficacy, superior patient compliance, and simplified administration, distribution, and storage logistics. Micron Biomedical is a clinical stage biopharmaceutical company on a rapid path to commercialize its proprietary applicator-free, dissolving, microneedle patch technology designed to achieve better health outcomes through enhanced therapeutic effects, simplified logistics, and improved patient compliance. Simple and/or self-administration delivery technology, such as Micron’s, that doesn’t require intramuscular injection or a cold chain, with no sharps waste, is a critical innovation to making vaccines easier to administer and distribute, expanding access globally.